executive vice president of the thrombosis business unit at Leo, added details about how his team will handle the product, explaining that the drug complements the company’s “existing heparin ...

LEO Pharma will manage the distribution ... focuses on a speciality hospital product that complements our existing heparin-based anti-coagulation treatments for cancer-associated thrombosis ...